Saturday, December 8, 2012

• Don't Be Surprised If Underpriced Small-Cap Biotechs Catch Investors' Eye Once Againat Forbes (Sat, Dec 8)

Friday, December 7, 2012

• PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements andEDGAR Online (Fri, Dec 7)

Thursday, December 6, 2012

• Pacira licenses Exparel for veterinary usesAP (Thu, Dec 6)
• Pacira Pharmaceuticals and Aratana Therapeutics enter global licensing agreementtheflyonthewall.com (Thu, Dec 6)
• Pacira Pharmaceuticals, Inc. and Aratana Therapeutics Inc. Enter into Global Licensing Agreement for Development and Commercialization of Bupivacaine Liposome Injectable Suspension for Animal Health IndicationsBusiness Wire (Thu, Dec 6)
• Pacira Could Be The Next Pharma Stock You Wished You Ownedat Seeking Alpha (Thu, Dec 6)

Tuesday, December 4, 2012

• PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements andEDGAR Online (Tue, Dec 4)

Tuesday, November 20, 2012

• Pacira Pharmaceuticals, Inc. to Present at the 24th Annual Piper Jaffray Healthcare ConferenceBusiness Wire (Tue, Nov 20)
• New Data Demonstrate Reduction in Opioid Use, Hospital Cost and Length of Stay with EXPAREL as the Foundation of a Multimodal RegimenBusiness Wire (Tue, Nov 20)

Tuesday, November 13, 2012

• New Data Supporting Use of EXPAREL via Infiltration into the Transversus Abdominis Plane Presented at 11th Annual American Society of Regional Anesthesia and Pain Medicine MeetingBusiness Wire (Tue, Nov 13)

Thursday, November 8, 2012

• Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare ConferenceBusiness Wire (Thu, Nov 8)

Wednesday, November 7, 2012

• The Most Promising Dividends in Pharmaceutical Companiesat Motley Fool (Wed, Nov 7)

Friday, November 2, 2012

• Pacira Pharmaceuticals Beats on the Top Lineat Motley Fool (Fri, Nov 2)

Thursday, November 1, 2012

• PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online (Thu, Nov 1)

Friday, October 19, 2012

• Tangoe Retains $28 Price Target and 1 Stock Analysis to Eyeat Wall St. Cheat Sheet (Fri, Oct 19)

Monday, October 8, 2012

• Healthcare Hedge Fund is Selling This Pharma Stock, Should You Too?at Motley Fool (Mon, Oct 8)

Thursday, September 27, 2012

• No Pain, Big Gains for This Pharma Stock?at Motley Fool (Thu, Sep 27)

Thursday, September 20, 2012

• Affordable Care Act (ACA) is No Longer an Issue for Biotech Stock Valuations: Interview with UBS Investment Bank Expert AnalystWall Street Transcript (Thu, Sep 20)
• Developments in Hepatitis C, HIV, Rheumatoid Arthritis Therapies Propel Growth in Biotech: Interview with UBS Investment Bank Expert AnalystWall Street Transcript (Thu, Sep 20)
• Shire Plc and Other Big Movers In Healthcare on September 20, 2012at Investopedia (Thu, Sep 20)

Tuesday, September 18, 2012

• 5 Highly Shorted Small-Caps With Strong Insider And Institutional Buyingat Seeking Alpha (Tue, Sep 18)
• Healthcare Stocks, Including Onyx Pharmaceuticals, Making Big Moves on September 18, 2012at Investopedia (Tue, Sep 18)

Thursday, September 13, 2012

• Healthcare Stocks, Including Smith & Nephew plc, Making Big Moves on September 13, 2012at Investopedia (Thu, Sep 13)

Tuesday, September 11, 2012

• 3 Small Cap 'Buy' Rated Stocks With Institutional And Insider Buyingat Seeking Alpha (Tue, Sep 11)

Tuesday, August 28, 2012

• Pharmacyclics Among Healthcare's Biggest Movers on August 28, 2012at Investopedia (Tue, Aug 28)

Add PCRX News to My Yahoo!